Walking assessment with instrumented insoles in patients with lower limb spasticity after botulinum toxin infiltration;Valoración de la marcha mediante plantillas instrumentadas en pacientes con espasticidad de miembros inferiores tras infiltración con toxina botulínica

Neurologia

Volumn 27, Issue 9, 2012, Pages 519-530

  Beseler M R ^a   Grao, C M ^a   Gil, A ^b   Martinez Lozano M D ^a  

^a Hospital La Magdalena   (Spain)

^b HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

Author keywords

Botulinum toxin; Instrumented insoles; Spasticity; Spinal cord injury; Stroke; Traumatic brain injury

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; BIOMECHANICS; BRAIN INJURY; CLINICAL ARTICLE; CLINICAL EXAMINATION; FUNCTIONAL ASSESSMENT; GAIT; HUMAN; JOINT; LEG; MUSCLE SPASM; MUSCLE TONE; PATIENT SATISFACTION; SPASTICITY; WALKING;

ADULT; AGED; BOTULINUM TOXINS, TYPE A; FEMALE; FOOT; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; MIDDLE AGED; MUSCLE SPASTICITY; NEUROLOGIC EXAMINATION; NEUROMUSCULAR AGENTS; WALKING;

EID: 84868617232     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2011.07.007     Document Type: Article

References (25)

1. Lance J.W. Symposium sinopsis. Spasticity: disorder motor control 1980, 485-495. Year Book Medical Publishers, Chicago. R.G. Friedman, R.R. Young, W.P. Koella (Eds.).
2. Mayer H., Esquenazi A., Childers M. Common paterns of clinical motor dysfunction. Spasticity: etiology, evaluation, management and the role of botulinum toxin. 2002, 16-26. We Move, New York. M.H. Mayer, D.M. Simpson (Eds.).
3. Leavitt L.A., Zuniga E.N., Calvert J.C., Canzoneri J., Peterson C.R. Gait analysis of normal subjets. South Med J 1971, 64:1131-1138.
4. Bobain G., Valentini F., Renard-Demel S., Chennevelle J.M., Piera J.B. A baropodometric parameter to analyze the gait of hemiparetic patients: the path of center of pressure. Ann Readapt Med Phys 2006, 49:609-613.
5. Bohannon R.W., Smith M.B. Interrater reliability of a modified Asworth scale of mucle spasticity. Phys Ther 1987, 67:206-207.
6. Kimura J (editor). Muscle and nerve. spasticity: etiology, evaluation, management and the role of botulinum toxin A. Patients Visit Forms And Rating Scales (appendix). 1997;Supl 6.
7. Aids to the investigation of peripheral nerve injuries. War Memorandum N. 7 1943, Medical Reseach Council, His Magesty's Stationery Office, London.
8. Holden M.K., Gill K.M., Magliozzi M.R., Nathan J. Gait assement for neurologically impaired patients. Standars for outcome assessment. Phys Ther 1986, 66:1530-1539.
9. Viosca E., Martínez J.L., Almagro P., Gracia A., González C. Proposal and validation of a new functional ambulation classification scale for clinical use. Arch Phys Med Rehabil 2005, 86:1234-1238.
10. Chambers C.T., Craig K.D. An intrusive impact of anchors in children's FACES pain scales. Pain 1998, 78:27-37.
11. Fock J., Galea M.P., Stilman B.C., Rawicki B., Clark M. Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury. Brain Injury 2004, 18:57-63.
12. Caty G.D., Detrembleur C., Bleyenheuft C., Deltombe T., Lejeune T.M. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait. Stroke 2008, 39:2803-2808.
13. Rosales R.L., Chua-Yap A.S. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity. J Neural Transm 2008, 115:617-623.
14. Marciniak C., Rader L., Gagnon C. The use of botulinum toxin for spasticity after spinal cord injury. Am J Phys Med Rehabil 2008, 87:312-317.
15. Rousseaux M., Launay M.J., Kozlowski O., Daveluy W. Botulinum toxin injection in patients with hereditary spastic paraparesis. Eur J Neurol 2007, 14:206-212.
16. Fheodoroff K., Wissel J., Entner T., Freimüller M. Measurement outcome in spasticity rehabilitation. Wien Klin Wochenschr 2001, 113(Suppl 4):11-15.
17. Gracies J.M., Lugassy M., Weisz D.J., Vecchio M., Flanagan S., Simpson D.M. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study. Arch Phys Med Rehabil 2009, 90. 9-16.e2.
18. Hoyos J.V., Lafuente R., Sánchez-Lacuesta J., Prat J., Soler-García C. El laboratorio de análisis de la marcha humana. Biomecánica de la marcha humana 1993, 321-368. Instituto de Biomecánica de Valencia, Valencia. J. Prat (Ed.).
19. Robertson J.V., Pradon D., Bensmail D., Fermanian C., Roche N. Relevance of botulinum toxin injection and nerve lock of rectus femoris to kinematic and functional parameters of stiff knee gait in hemiplegic adults. Gait posture 2009, 29:108-112.
20. Bleyenheuft C., Cookx S., Caty G., Stoquart G., Lejeune T., Detrembleur C. The effect of botulinum toxin injections on gait control in spastic stroke patients presenting with a stiff-knee gait. Gait Posture 2009, 30:168-172.
21. Martínez Nova A., Cuevas García J.C., Pascual Huerta P., Sánchez Rodríguez R. BioFoot® in shoe-system: Normal values and assessment of reliability and repeatibility. The Foot 2007, 17:190-196.
22. Perry J. Gait analysis. Normal and pathological function 1992, Slack Incorporated, New York.
23. Papadonikolakis A.S., Vekris M.D., Korompilias A.V., Kostas J.P., Ristanis S.E., Soucacos P.N. Botulinum A toxin for treatment of lower limb spsticity in cerebral palsy:gait analysis in 49 patients. Acta Orthop Scand 2003, 74:749-755.
24. Randolf A.L., Nelson M., Akkapeddi S., Levin A., Alexandrescu R. Reliability of measurements of pressures applied on the foot during walking by a computerized insole sensor system. Arch Phys Med Rehabil 2000, 81:573-578.
25. Bryant A.R., Tinley P., Singer K.P. Normal values of plantar pressure measurements determined using the EMED-SF system. J Am Podiatr Med Assoc 2000, 90:295-299.